Bryant, Ashley Leak
LeBlanc, Thomas W.
Albrecht, Tara
Chan, Ya-Ning
Richardson, Jaime
Foster, Matthew
Dang, Malisa
Dudley, William
Owenby, Susie
Wujcik, Debra
Funding for this research was provided by:
Astellas, Inc (None)
Article History
Received: 23 November 2019
Accepted: 4 February 2020
First Online: 14 February 2020
Compliance with ethical standards
: The study was reviewed and approved by the University of North Carolina at Chapel Hill Institutional Review Board (IRB). Informed consent was obtained by all participants prior to joining the groups.
: Dr. Bryant has received grants from Carevive during the conduct of the study and honorarium outside the submitted work. Dr. Leblanc has received personal fees from AbbVie, personal fees from Agios, grants and personal fees from AstraZeneca, personal fees from Amgen, personal fees from CareVive, personal fees and other from Celgene, personal fees from Daiichi-Sankyo, personal fees from FlatIron, personal fees from Helsinn, personal fees from Heron, personal fees from Medtronic, personal fees from Otsuka, personal fees from Pfizer, grants and personal fees from Seattle Genetics, personal fees from UpToDate, personal fees from Welvie, grants from American Cancer Society, grants from Duke University, grants from NINR/NIH, grants from Jazz Pharmaceuticals, outside the submitted work. Ms. Chan has received assistantship, and scholarship from University of North Carolina at Chapel Hill outside the submitted work. Ms. Richardson has provided consulting for Roche/Ventana outside the submitted work. Dr. Foster has received grants from Celgene, grants from MacroGenics, grants from Bellicum Pharmaceuticals, other from Daiichi-Sankyo, outside the submitted work. Dr. Dudley has received consultation fee from Carevive Systems, Inc. during the conduct of the study. Ms. Owenby and Dr. Wujcik are employed by Carevive System, Inc. during the conduct of the study. Dr. Albrecht and Ms. Dang have no conflict of interest to disclose.